Metabolic syndrome after hormone-modifying therapy: risks associated with antineoplastic therapy.
Redig
Amanda J
AJ
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. aredig@partners.org
Munshi
Hidayatullah G
HG